Clinical trial
Establishing a Tumor Bank in Families With Multiple Lymphoproliferative…
NCT00131014 · Dana-Farber Cancer Institute, Other · Recruiting
Key facts
| NCT number | NCT00131014 |
|---|---|
| Title | Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies |
| Official title | Establishing a Tumor Bank and Initial Analysis of Germline and Tumor-Related Genetic Alterations in Families With Multiple Lymphoproliferative Malignancies |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Status | Recruiting |
| Study type | Observational |
| Conditions | Non-Hodgkin's Lymphoma, Hodgkin's Disease, Leukemia, Lymphocytic, Chronic, Lymphoproliferative Disorders |
| Enrollment | 1,500 |
| Start date | Aug 9, 2004 |
| Primary completion | Jan 1, 2033 |
| Completion | Jan 1, 2033 |
| First posted | Aug 17, 2005 |
| Last update posted | Jul 22, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: